BRIEFING - ASIA HEALTH - MAY 6, 2009Manufacturing Business Technology, ILMELBOURNE - Australian drug developer Pharmaxis Ltd (ASX:PXS) says an international Phase III clinical trial of its compound Bronchitol to determine whether it would improve lung function in people with cystic fibrosis has produced positive results. ...